CINECA IRIS Institutional Research Information System

CALDERONE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.535
AS - Asia 12.469
EU - Europa 9.611
SA - Sud America 1.744
AF - Africa 499
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 9
Totale 47.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.835
SG - Singapore 4.040
IT - Italia 3.588
CN - Cina 3.426
HK - Hong Kong 1.867
BR - Brasile 1.449
SE - Svezia 1.323
VN - Vietnam 1.193
DE - Germania 1.038
BG - Bulgaria 716
FR - Francia 549
CA - Canada 527
GB - Regno Unito 510
FI - Finlandia 464
TR - Turchia 454
RU - Federazione Russa 362
KR - Corea 299
IN - India 267
UA - Ucraina 255
JP - Giappone 241
AT - Austria 202
CI - Costa d'Avorio 186
PL - Polonia 129
BD - Bangladesh 118
CH - Svizzera 115
NL - Olanda 97
IQ - Iraq 94
MX - Messico 90
AR - Argentina 85
ZA - Sudafrica 66
SN - Senegal 58
PK - Pakistan 53
SA - Arabia Saudita 53
ID - Indonesia 49
BE - Belgio 47
UZ - Uzbekistan 45
CO - Colombia 44
ES - Italia 43
EC - Ecuador 40
VE - Venezuela 37
KE - Kenya 32
MA - Marocco 31
AU - Australia 27
NG - Nigeria 26
IL - Israele 25
PE - Perù 25
GR - Grecia 23
PH - Filippine 23
TN - Tunisia 23
CL - Cile 22
MY - Malesia 22
JO - Giordania 20
EG - Egitto 19
JM - Giamaica 19
AZ - Azerbaigian 18
HU - Ungheria 18
AE - Emirati Arabi Uniti 16
IE - Irlanda 16
KZ - Kazakistan 16
NP - Nepal 16
PS - Palestinian Territory 16
PY - Paraguay 16
CZ - Repubblica Ceca 15
IR - Iran 15
DZ - Algeria 14
LT - Lituania 14
BO - Bolivia 13
OM - Oman 13
UY - Uruguay 13
KG - Kirghizistan 12
AL - Albania 11
CR - Costa Rica 11
LB - Libano 10
NI - Nicaragua 9
SK - Slovacchia (Repubblica Slovacca) 9
TW - Taiwan 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
HN - Honduras 8
HR - Croazia 8
MD - Moldavia 8
PT - Portogallo 8
BJ - Benin 7
BY - Bielorussia 6
NZ - Nuova Zelanda 6
RO - Romania 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
EE - Estonia 5
EU - Europa 5
KH - Cambogia 5
MK - Macedonia 5
RS - Serbia 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
BH - Bahrain 4
GE - Georgia 4
LK - Sri Lanka 4
Totale 47.830
Salva come PNG Salva come JPEG
Città #
Ashburn 2.352
Singapore 2.292
Woodbridge 2.131
Hong Kong 1.837
Ann Arbor 1.651
Fairfield 1.557
Houston 1.385
San Jose 1.335
Chandler 1.240
Santa Clara 1.196
Dallas 1.030
Milan 742
Serra 728
Sofia 715
Shanghai 690
Beijing 664
Seattle 649
Wilmington 576
Cambridge 531
New York 526
Boardman 437
Ottawa 391
Hefei 377
Los Angeles 375
Princeton 313
Jacksonville 305
Council Bluffs 298
Lawrence 285
Seoul 273
Ho Chi Minh City 270
Izmir 267
Lauterbourg 252
Medford 236
Tokyo 227
Chicago 212
Hanoi 204
Nanjing 204
Helsinki 187
Abidjan 186
Dong Ket 186
Vienna 181
Frankfurt am Main 180
Des Moines 169
Pisa 158
Munich 157
Buffalo 148
London 143
Rome 133
Istanbul 120
Florence 118
São Paulo 112
Redondo Beach 111
Dearborn 107
Warsaw 105
San Diego 93
Orem 87
Nanchang 84
Boulder 77
Columbus 71
The Dalles 68
Redwood City 67
Bern 62
Dakar 58
Marseille 55
Lucca 52
Ogden 52
Jüchen 50
Da Nang 49
Zurich 49
Washington 48
Livorno 47
Shenyang 45
Turku 45
Brussels 44
Salt Lake City 44
Changsha 43
Kunming 43
Rio de Janeiro 43
Tianjin 42
Grafing 41
Naples 41
Nuremberg 38
Pune 38
Atlanta 37
Belo Horizonte 37
Hebei 37
Tashkent 37
Baltimore 36
Chennai 36
Fuzhou 36
Phoenix 36
Montreal 35
Guangzhou 34
Paris 34
Brooklyn 33
Falls Church 33
Amsterdam 32
Norwalk 32
Toronto 32
Baghdad 31
Totale 33.418
Salva come PNG Salva come JPEG
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 393
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 303
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 299
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 293
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 288
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 284
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 268
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 257
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 248
Antioxidant, cardiomyocyte anti-ageing properties and phytochemical profile of Citrus bergamia juices 247
Antioxidant and Antisenescence Effects of Bergamot Juice 246
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 242
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 237
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 234
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 232
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 226
Metformin conjugates and therapeutic use thereof 225
Memantine prodrug as a new agent for alzheimer’s disease 225
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 224
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 222
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 222
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 222
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 220
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 217
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 215
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 215
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 214
An update on hybrid drugs in cardiovascular drug research 207
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 207
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 206
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 204
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 204
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 203
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 203
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 199
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 199
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 198
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 197
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 196
Resveratrol-like Compounds as SIRT1 Activators 195
An alternative method to evaluate the nature of an antagonist and its potency. A theoretical approach 194
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 194
Synthesis of 1,8-naphthyridine derivatives: potential antihypertensive agents. Part VIII 193
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 192
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 192
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 188
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method 186
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 186
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 186
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 185
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 185
Synthesis of 1,8 - naphthyridine derivatives: potential antihypertensive agents. Part VII 185
New amido derivatives as potential BKCa potassium channel activators. XI 184
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 183
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 181
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 181
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 180
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 179
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 179
A modified aortic multiple-ring preparation for functional studies 179
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 179
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 179
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 178
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 176
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 176
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 175
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 174
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 174
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 174
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 173
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 173
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 173
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 173
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 173
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 172
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 172
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 172
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 170
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 170
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 170
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 170
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 168
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 168
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 168
Antiviral properties of an aqueous extract of a green algae Caulerpa taxifolia (Vahl) C. Agardh. 167
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 166
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 165
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 165
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 165
Intrinsic activity and EC50: the simplest tools for the evaluation of the dissociation constant of a partial agonist 162
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 162
Cinnamides Target Leishmania amazonensis Arginase Selectively 162
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 161
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 160
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 159
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 159
Synthesis and b-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]-pyridine: potential antihypertensive agents. Part IX 159
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 153
Totale 19.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 0 0 438
2021/20223.287 63 220 98 159 537 536 107 172 130 108 252 905
2022/20234.211 523 540 277 346 465 575 41 272 808 24 212 128
2023/20243.300 333 405 373 189 467 624 147 95 59 88 125 395
2024/202510.363 95 411 126 559 850 1.123 809 581 1.007 1.345 1.286 2.171
2025/202612.806 703 1.485 1.323 1.077 1.268 1.199 2.117 656 936 1.304 448 290
Totale 48.867